Theralase Technologies Inc. V.TLT

Asco Gu abstract released

[DJDawg]

https://meetings.asco.org/abstracts-presentations/216828

[DJDawg]

As expected, based on the deadline for abstract submission back in Oct. The abstract reports. Assessment 90 Day 180 Day 270 Day 360 Day 450 Day CR 50% 47% 41% 35% 21% IR 16% 26% 22% 12% 13% Total Response 66%

[Eoganacht]

It's good to remember that 8 of the 24 evaluable patients were undertreated and did not receive an optimized treatment. So 33% of the sample of  24 patients had no chance of a CR. 21% CR at 450 days in no way reflects the actual efficacy of the treatment. As mentioned by DJDawg, in the more recent data release from Nov. 29 the CR rate at 450 days was 28%. If just 2 of the 8 completely

[fredgoodwinson]

Yes Eog - really can`t see what`s holding it back. BTW is the vaccine being trialled in humans yet?  Thanks.

[Eoganacht]

Hi Fred - it looks like it will be 2024 before human testing begins. 2023 will be devoted to testing the vaccine in animals. This is from the latest MD&A: In July 2022, Theralase® executed a Testing and Technical Services Agreement (“TTSA”) with the National Research Council of Canada (“NRC”) to produce inactivated SARS-CoV-2 virus using Theralase®’s patented PDC and proprietary

[ScienceFirst]

Eoganacht ... I agree.  The more patients we add to our sample, the higher will be our efficacy %s.

[hilles]

Look very good to me. Imagine if we treat the patient every 180 days....!

[ScienceFirst]

Apart data, which is phenomenal when compared to competition and that confirms my previous posts on potential upcoming efficacy %s around 65%+ @450-days as we add more and more optimized patients and will secure a FDA approval in due time, there are these others things that are very interesting in this poster: 1) Excellent Safety profile: None of the SAEs were deemed to be directly related to

[ScienceFirst]

TR% of 65%+ will allow patients to avoid/delay any cystectomy.  The FDA cannot disregard this.  Expects Breakthrough Therapy designation and/or Accelerated Approval with complete FDA approval in due time.

[FGPstock]

tuesday is typically news day, lets hope they put some more positive data out before the presentation...

[Oilminerdeluxe]

A new ATH would be nice to see some day. Sigh, 38 cents. Maybe the next update or two will do the trick. That usually does not happen. But here's to hoping!